COVID-19 Information: Learn more.

Emily Bibak MS, PhD


About:

Dr. Emily N. Bibak is currently an adjunct faculty member of the Ric Scalzo Botanical Research Institute and the Vice President of Research and Development at SHC Hyland’s Inc. Previously, she designed, managed, led and implemented analytical activities for all stages of drug product development for a global pharmaceutical company. In addition, Dr. Bibak was the Director of Process Sciences at SHC Hyland’s Inc where she designed and supervised establishment of  an analytical laboratory for research. She has two patents and several published articles.

Education:

  • Heidelberg University, Germany (Ph. D. in Pharmaceutical Chemistry)
  • Linkoping University, Sweden (Master of Science, Chemistry)

Publications:

  • R. Rosseto, N. Bibak, R. Deocampo, T. Shah, A. Gabrielian, J. Hajdu. “A New Synthesis of Lysophosphatidylcholines and Related Derivatives. Use of p-Toluenesulfonate for Hydroxyl Group Protection.” J. Org. Chem., 2007, 72(5), 1691-1698.
  • R. Rosseto, N. Bibak, J. Hajdu. “A new approach to phospholipid synthesis using tetrahydropyranyl glycerol: rapid access to phosphatidic acid and phosphatidylcholin, including mixed-chain glycerophospholipid derivatives.” Organic & Biomolecular Chemistry, 2006, 4, 2358-2360.
  • N. Bibak, R.M. Paul, D.M. Freymann, N.R. Yaseen. “Purification of RanGDP, RanGTP, and RanGMP-PNP by ion-exchange chromatography.” Analytical Biochemistry, 2004, 333(1):57-64.
  • R. Rosseto, N. Bibak, J. Hajdu. “Preparation of lysophosphatic acid and lysophosphatidylcholine from p-nitrophenyl glycerate.” Tetrahedron Letters, 2004, 45: 7371-7373.
  • N. Bibak, J. Hajdu. “A new approach to the synthesis of lysophosphatidylcholines.” ACS, 2003, Abstract ID # 650506.
  • N. Bibak, J. Hajdu. “A new approach to the synthesis of lysophosphatidylcholines and related derivatives.” Tetrahedron Letters, 2003, 44: 5875-5877.
  • H.P. Deigner, R. Claus, G.A. Bonaterra, N. Bibak, M. Blaess, M. Cantz, J. Metz, R. Kinscherf. “Ceramide induces aSMase expression: Implications for oxLDL-induced apoptosis.” FASEB J., 2001, 15: 807-814.